ITRM reaches another signed rebate agreement with one of the top three Medicare Part D Pharmacy Benefit Managers;

Iterum has been granted a patent in the United States  that covers a bilayer tablet comprising sulopenem etzadroxil and probenecid.

• No comments yet. Be the first to comment!